Safety of Autologous Cord Blood Cells for Preterms: A Descriptive Study

Table 3

No	Volume collected	Volume postprocessing	Cells collected (108)	Cells postprocessing (108)	Cell concentration postprocessing106/ml	CFU-GM/105	CD34+/106	Viability	Infused NC107/kg	Infused age (H)	Infused volume	Pathogen detection
1	34	22	1.82	1.46	6.65	1.84	1.1	100	4.48	5	11	Negative
2	35	20	1.6	1.32	5.82	1.98	0.7	99.5	5	6	13	Negative
3	61	24	2.44	1.67	6.95	2.3	1.14	99.8	5	7	12	Negative
4	33	16	0.97	0.86	5.4	0.72	0.31	99.8	5	4	14	Negative
5	36	22	1.43	1.21	5.5	1.57	0.59	99.8	5	9	13	Negative
6	28	16	1.43	1.23	7.7	1.53	0.9	99.5	5	4.5	11	Negative
7	55	28	5.81	5.43	26.3	11.27	5.69	99.8	5	6	3	Negative
8	65	20	2.99	2.37	11.85	1.66	1.66	99.9	5	7	8	Negative
9	81	20	6.14	4.33	21.65	9.96	3.9	99.9	5	8	5	Negative
10	27	28	2.21	1.97	7.05	3.35	0.55	99.8	5	8	28	Negative
11	46	24	2.96	2.65	13.6	3.32	1.01	99.5	5	7	6	Negative
12	37	24	1.51	1.4	5.85	1.04	0.08	99.9	5	9	12	Negative
13	24	22	1.72	1.58	8.53	2.82	1.1	99.8	5	6	9	Negative
14	69	24	8.11	7.83	40.8	6.08	16.22	99.8	5	7	2	Negative
15	76	30	5.3	4.7	22.8	6.39	1	99.5	5	8	7	Negative
Mean	47.13	22.67	3.10	2.67	13.10	3.72	2.40	99.7	4.97	6.77	10.27
SD	19.10	4.05	2.17	2.00	10.35	3.25	4.10	0.17	0.13	1.52	6.18